Summary: The clinical trial results show that the vaccine is safe and effective in this in this age group, it will thus…
Corona
-
-
AstraZenecaPharma Science & Research
France HAS Approves AstraZeneca’s Evusheld for High-Risk Covid Cases
by adminby adminSummary – French health authorities have approved the use of an antibody treatment made by AstraZeneca for high-risk people who show resistance…
-
CompaniesPfizer
Booster dose of Pfizer-BioNTech vaccine Necessitate for Shielding Against Omicron
by adminby adminSummary – Pfizer says the protection provided by two doses of its anti-COVID-19 vaccine against previous strains will match that provided by…
-
Summary : The Pfizer COVID-19 vaccine provides less immunity against Omicron than from other coronavirus variants, according to a lab study that…
-
Agro Science & Research
Cotton Corporation of India gets price assistance from the Cabinet.
by adminby adminThe Cabinet Committee on Economic Affairs (CCEA) on Wednesday gave approval for committed price support of ₹17,408.85 crore to the Cotton Corporation…
-
IndiaPharma Science & Research
The NTAGI is Considering Giving Immunocompromised Persons a “Additional” Dosage of COVID-19 Vaccination.
by adminby adminSynopsis: A booster dose is given to an individual after a predefined period when the immune response due to primary vaccination is…
-
CompaniesPfizer
Pfizer/Covid BioNTech’s vaccine for younger children has been moved up to December 13 by the European Union.
by adminby adminThe European Union-wide rollout of Pfizer and BioNTech’s Covid-19 vaccine version for five- to 11-year-old children will begin Dec 13, one week…
-
Synopsis : Zydus Cadila’s COVID-19 vaccine ZyCoV-D will be initially introduced in seven States including Bihar, Jharkhand, Maharashtra, Punjab, Tamil Nadu, Uttar…
-
Pharma Science & Research
Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in Indonesia
by adminby adminNovavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of…
-
Active Pharmaceutical Ingredients (API)COVAXIndia
Serum Institute looks to supply 25 million doses to Covax till December
by adminby adminPune-based Serum Institute of India (SII) is expected to supply 25 million doses to the Covax facility till December, as it looks…